Covid-19 News

COVID-19

• Communicable disease threats report, 30 November - 6 December 2024, week 49 December 6, 2024
  This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 November - 6 December2024 and includes updates on increases in respiratory infections due to Mycoplasma pnemoniae in the EU/EEA, SARS-CoV-2 variant classification, Influenza A(H5N1), Avian influenza, Middle East respiratory syndrome, an unknown disease in the Democratic Republic of the Congo, mpox, […]
• Weekly respiratory virus update, week 48, November 2024 December 6, 2024
  In EU/EEA countries, respiratory syncytial virus (RSV) activity remains high. Influenza activity remains low but is slowly increasing. SARS-CoV-2 activity remains at low levels.
• Reporting Protocol for integrated respiratory virus surveillance December 4, 2024
  This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
• COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network - October 2023 to April 2024 December 3, 2024
  This document reports the results of prospective monitoring of COVID-19 vaccine effectiveness.
• Weekly respiratory virus update, week 47, November 2024 November 29, 2024
  In EU/EEA countries, a sharp increase was observed in respiratory syncytial virus (RSV) activity, marking the start of the epidemic wave. Influenza and SARS-CoV-2 activities remained at low levels.
• Communicable disease threats report, 16-22 November 2024, week 47 November 22, 2024
  This issue of the CDTR covers the period 16-22 November 2024 and includes updates on chikungunya, dengue, avian influenza, West Nile virus, mpox, severe floods in eastern Spain, identification of cVDPV2 in sewage samples, and an overview of respiratory virus epidemiology in the EU/EEA.
• Weekly respiratory virus update, week 46, November 2024 November 22, 2024
  In EU/EEA countries, a sharp increase was observed in respiratory syncytial virus activity, marking the start of the epidemic wave. Influenza and SARS-CoV-2 activities remained at relatively low levels.
• European SARS-CoV-2 and influenza Bioinformatics External Quality Assessment (ESIB-EQA), 2023 November 18, 2024
  The objective of this External Quality Assessment (EQA) is to strengthen the capacity for genomic epidemiology and public health bioinformatics.
• Weekly respiratory virus update, week 45, November 2024 November 15, 2024
  In the EU/EEA countries, activity of influenza viruses, respiratory syncytial viruses and SARS-CoV-2 continue to remain at relatively low levels.
• Weekly respiratory virus update, week 44, October-November 2024 November 12, 2024
  Activity of influenza viruses, respiratory syncytial viruses and SARS-CoV-2 remained at relatively low levels in week 44 in the EU/EEA countries.